Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2007 | 1 |
2008 | 2 |
2009 | 1 |
2010 | 1 |
2011 | 1 |
2013 | 1 |
2014 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Modulation of ErbB2 blockade in ErbB2-positive cancers: the role of ErbB2 Mutations and PHLDA1.
PLoS One. 2014 Sep 19;9(9):e106349. doi: 10.1371/journal.pone.0106349. eCollection 2014.
PLoS One. 2014.
PMID: 25238247
Free PMC article.
Combined histone deacetylase and cyclooxygenase inhibition achieves enhanced antiangiogenic effects in lung cancer cells.
Wang X, Li G, Wang A, Zhang Z, Merchan JR, Halmos B.
Wang X, et al.
Mol Carcinog. 2013 Mar;52(3):218-28. doi: 10.1002/mc.21846. Epub 2011 Nov 28.
Mol Carcinog. 2013.
PMID: 22121107
Free PMC article.
Item in Clipboard
Molecular testing in lung cancer: the time is now.
Cheng H, Xu X, Costa DB, Powell CA, Halmos B.
Cheng H, et al.
Curr Oncol Rep. 2010 Sep;12(5):335-48. doi: 10.1007/s11912-010-0118-z.
Curr Oncol Rep. 2010.
PMID: 20623207
Review.
Item in Clipboard
Dysregulation of the C/EBPalpha differentiation pathway in human cancer.
Koschmieder S, Halmos B, Levantini E, Tenen DG.
Koschmieder S, et al.
J Clin Oncol. 2009 Feb 1;27(4):619-28. doi: 10.1200/JCO.2008.17.9812. Epub 2008 Dec 15.
J Clin Oncol. 2009.
PMID: 19075268
Free PMC article.
Review.
Item in Clipboard
15-Hydroxyprostaglandin dehydrogenase is a target of hepatocyte nuclear factor 3beta and a tumor suppressor in lung cancer.
Huang G, Eisenberg R, Yan M, Monti S, Lawrence E, Fu P, Walbroehl J, Löwenberg E, Golub T, Merchan J, Tenen DG, Markowitz SD, Halmos B.
Huang G, et al.
Cancer Res. 2008 Jul 1;68(13):5040-8. doi: 10.1158/0008-5472.CAN-07-6575.
Cancer Res. 2008.
PMID: 18593902
Free PMC article.
Item in Clipboard
Resistance to an irreversible epidermal growth factor receptor (EGFR) inhibitor in EGFR-mutant lung cancer reveals novel treatment strategies.
Yu Z, Boggon TJ, Kobayashi S, Jin C, Ma PC, Dowlati A, Kern JA, Tenen DG, Halmos B.
Yu Z, et al.
Cancer Res. 2007 Nov 1;67(21):10417-27. doi: 10.1158/0008-5472.CAN-07-1248.
Cancer Res. 2007.
PMID: 17974985
Item in Clipboard
Cite
Cite